|
A
Leading Investigator’s “Perspective Review” of
the Year 2007 AHA/ACC Guidelines for Non-ST Elevation Myocardial
Infarction
Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP
The
Evolving Antithrombotic Landscape for Patients with ST-Elevation
Myocardial Infarction – What’s
on the HORIZON?
Gregg W. Stone, MD, FACC
Getting
in the Stream of Antithrombotic Therapy for ACS – What
Do the Trials Tell Us? To Switch or Not to Switch
Ron Waksman, MD, FACC
Bleeding, Mortality and Risk Profiling for Invasive Vascular
Management of ACS
Steven V. Manoukian, MD, FACC
Critical Challenges in Acute, Ischemic
Heart Disease – Where
Metal Meets Thrombus, Drugs and Vascular Endothelium
E. Magnus Ohman, MD
The Year 2007 AHA/ACC Guidelines for Non-ST Elevation Myocardial
Infarction: The Reinvention of Pharmacologic Intervention
A. Michael Lincoff, MD
Getting
in the Stream of Antithrombotic Therapy for ACS – What
Do the Trials Tell Us?
C. Michael Gibson, MS, MD
The
Year 2007 ACC/AHA Guidelines and Upstream Therapy — How
Do We Collaborate Across Best Evidence?
Charles V. Pollack, Jr., MS, MD, FACEP, FAAEM
Innovations in Acute Blood Pressure Management
Joseph Varon, MD, FCCP
Perfusion, Pressures, Problems, and Pragmatism
Paul Vespa, MD
Optimizing Blood Pressure Management in the Cardiovascular
and Cardiothoracic Surgery Setting
Jerrold H. Levy, MD
Characterization and Approach to Acute Blood Pressure Elevations
Across the Cardiovascular Disease Continuum
Christopher B. Granger, MD
Vascular Dysfunction Syndromes – Cardiovascular
Disease States Precipitating Acute, Life-Threatening Elevations
in Systemic Blood Pressure
James Ferguson, III, MD, FACC
Addressing
Acute Pressure Syndromes with Emerging Agents—The
ECLIPSE Trial and Implications for Cardiovascular Intensive
Care
Jerrold H. Levy, MD
Acute Severe Hypertension: Evolving Strategies and New Dimensions
of Emergency Cardiovascular Care
Charles V. Pollack, Jr., MS, MD, FACEP, FAAEM
New Dimensions and Critical Challenges In Osteoporosis:
The Internal Medicine and Primary Care Perspective
Mone Zaidi, MD, PhD, FRCP
Misconceptions
About Bisphosphonate Therapy — Separating
Fact From Fiction:
What Does the Clinician Need to Know About Safety and Efficacy
of Drug Therapy in Osteoporosis?
Paul D. Miller, MD
Patient
Screening and Assessment — Who,
When, and Why to Treat: Committing to Long-Term Therapy
Mone Zaidi, MD, PhD, FRCP
New
Dimensions and Landmark Advances in Osteoporosis Management —
Fracture Reduction and Mortality Outcomes: Comparing Therapeutic
Strategies
Felicia Cosman, MD
Case
Studies in Osteoporosis — Applying
Evidence and Guidelines to the Front Lines of Patient Management
Anthony I. Sebba, MD, FACR |
